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1. Introduction 
The high reactivity of the e-NH2 group of lysine 
residues offers the possibility of introducing very dif- 
ferent groups in the sidechain of this amino acid. 
These groups can alter different characteristics: e.g., 
length of the chain, charge, distance between the 
charge and the peptide backbone. When the positive 
charge of the e-NH, groups of lysine in luteinizing 
hormone is suppressed, the biological activity of this 
hormone is abolished [1,2]. However, if the positive 
charge is maintained, various chemical modifications 
of the e-NH, group can lead to gradual modification 
of the biological properties of the molecule ranging 
from the preservation of the total biological activity 
(e.g., with the methylated derivative) [l] to a com- 
bination of agonist and antagonist properties (e.g., 
with some guanidinated derivatives) [ 31. 
With the nitroguanidyl group, the positive charge 
is suppressed and the size of the introduced group 
rather increased in comparison to the methylated or 
guanidinated derivatives. This paper describes the 
physico-chemical and biological properties of the 
nitroguanidyl derivative of LH, the first well-defined 
antagonist obtained by chemical modification of the 
protein moiety in the gonadotropins. 
2. Materials and methods 
Ovine LH was prepared in a highly purified state 
(biological potency: 2 X LH-NIH, Sll) as in [4]. 
Abbreviations: LH, luteinizing hormone (lutropin); FSH, 
follicle-stimulating hormone (follitropin); G, guanidyl; NG, 
nitroguanidyl 
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Lutropin subunits were obtained by the countercurrent 
distribution method in [5]. Ovine follicle-stimulating 
hormone was kindly proyided by the National 
Pituitary Agency, Baltimore (MA) (NIAMDD-OFSH-13 
= 15, NIHFSH Sl). Cholera enterotoxin (27.8 lb/g 
Lowry protein) was purchased from Schwarz Mann 
(Orangeburg, NY) and prostadandin E2 from Sigma. 
I-Nitroguanyl-3,Sdimethyl pyrazol (Eastman Organic 
Chemicals) was used for nitroguanidylation, as in [6]. 
The degree of nitroguanidylation of amino acid 
residues was determined by amino acid analysis using a 
Technicon analyzer [ 61. 
Sucrose gradient sedimentation was done as in [ 71. 
Ovine LH was used as reference protein. Iffa Credo 
rats, 22 days old, were killed and the ovaries rapidly 
excised and minced. Using a loose-fitting glass homog- 
enizer the ovaries were homogenized in 5 mM Tris- 
HCl buffer (pH 7.4) containing 10 mM MgClz and 100 
mM sucrose. Ten up-and-down strokes were given with 
a Teflon rod. The homogenate (100 mg wet tissue/ml 
buffer) was then filtered through a layer of cheese 
cloth. The incubation medium for adenylate cyclase 
assay contained 33 mM Tris-HCl buffer (pH 7.41, 
3 mM MgS04, 2.5 mM NaCl, 0.1 mM GTP, 0.1 mM 
ATP, bovine serum albumin 0.2%, 11 mM phospho- 
enol pyruvate, pyruvate kinase 80 pg/ml, 8 mM theo- 
phylline and various amounts of hormone or deriva- 
tives. The reaction was started by adding the homog- 
enate (700 pg protein). It was allowed to proceed for 
10 min. at 37°C and stopped by addition of trichloro- 
acetic acid to give 5% final cont. The aliqots were used 
for determination of CAMP accumulation after centrif- 
ugation and extraction with diethyl ether [8]. 
The amount of CAMP was established as in [ 91. 
Radioactivity determinations were done using a 
Tricarb Packard liquid scintillation spectrometer. 
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3. Results Table 1 
3.1. Preparation and characterization of the n&o- 
Inhibition by addition of NG-LH of the LH-induced 
stimulation of ovarian adenylate cyclase 
guanidyl derivative 
Lutropin was treated by nitroguanyldimethylpyra- 
zole at room temperature in the dark for 24 h (10 mg 
protein, 40 mg reagent, 1 ml borate buffer, pH 10.3). 
The solution was then dialysed; first against asolution 
containing pyridine (1%) and NHJICO, (1%) and 
thereafter against apyridine solution (1%). It was 
lyophylized and submitted to gel filtration on Biogel 
P-30 and Biogel P-l 00 columns. Amino acid analysis 
showed that -9O%of the lysine residues were modified 
under these conditions. The preparation of the NG 
subunits was achieved in a similar manner (87% of 
lysine residues were modified). The elution volumes 
in the Biogel P-100 column (fig. 1) indicated an in- 
crease of the Stokes radius (rs) of the proteins after 
nitroguanidylation. NG-LH has rs -37 A, (native 
hormone, 30 a), and the NG subunits rs -30 A, 
(isolated subunit, 24 A). 
Treatment Remaining % 
stimulation 
(mean c SEMIa 
LHb 100 
LHb + 60 Mg NG-LH 66.50 * 5.45 
LHb + 120 pg NG-LH 55.25 f 8.76 
LHb + 180 peg NG-LH 34.75 i 3.88 
a Each value represents the mean of 4 determinations 
b Ovine LH, 80 pg/ml 
by incubation of juvenile rat ovarian homogenates in 
the presence of either LH or NG-LH. The presence of 
NG-LH in the medium induces a decrease of the cyclic 
AMP content of the homogenates under the basal level 
instead of the accumulation observed in the presence 
of LH. 
In sucrose gradient sedimentation experiments, the 
values found for the ratio SNG_&SLH (s, sedimenta- 
tion coefficient; NG-LH, nitroguanidyl LI-I) was 1.7. 
corresponding toa ratio Of&fNG_&&J.I (M, mol. wt) 
of -2.2. It may be concluded that in aqueous olution 
2 molecules of NG-LH associate. This may be due to 
the more hydrophobic haracter of the NG-group com- 
pared with the NH2 group. 
3.2. Biological characterization 
Fig. 2 shows the cyclic AMP accumulation obtained 
This inhibitory action of the NG-LH is clearly demon- 
strated when LH is added to the medium at the same 
time as NG-LH. As shown in table 1, the adenylate 
cyclase stimulation induced by a constant amounl of 
LH is decreased by the action of increasing concen- 
tration of NG-LH. When the incubation is performed 
in the presence of a constant amount of NG-LH and 
variable amounts of native LH (fig. 3), the cyclic AMP 
accumulation islower than that obtained in the pres- 
ence of LH alone, demonstrating once again the in- 
hibitory action of the derivative. However, increasing 
.HSU 
Y 2f \ 10 2’0 30 4’0 5’0 
fraction number 
Fig.1. Gel filtration on Biogel P-l 00 of 10 mg NG-LH (peak A) 
and 10 pg NG-LH OL subunit (peak B). Arrows indicate the 
elution volume of native LH and of the LH subunit. 
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Fig.2. Cyclic AMP accumulation induced in ovarian homoge- 
nates from juvenile rat by LH and NG-LH. 100% corresponds 
to 40 pmol cAMP/mg protein. 
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Fig.3. Cyclic AMP accumulation induced in rat ovarian homog- 
enates by increasing amounts of LH in the presence or in the 
absence of 40 etg NG-LH. 
amounts of LH can compensate for the inhibitory 
effect of NG-LH suggesting a competitive inhibition of 
the action of the hormone by the derivative. 
The specificity of this inhibitory action was investi- 
gated by incubating ovarian adenylate cyclase in the 
presence of different stimulating agents and NC-LH 
(table 2). No significant inhibitory effect on the stim- 
ulating action of azide, fluoride, prostaglandin Ez or 
Table 2 
Effect of NG-LH on the stimulation of ovarian 
adenylate cyclase induced by different effecters 
or by FSHa 
Effector NG-LH Stimulationb 
(fig/ml) (%I 
Azide 200 mM 
NaF 10 mM 





FSH 1 pg 
120 97.3 + 6.6 
180 99.8 f 8.7 
200 99.7 f 6.7 
60 90.3 f 6.9 
120 100.7 f 5.8 
180 90.6 f 4.5 
50 99.6 f 2.7 
100 95.3 f 9.7 
150 110.0 f 6.0 
150 99.5 * 6.5 
150 105.5 + 8.5 
50 104.0 f 3.0 
100 94.5 + 1.5 
200 100.0 f 4.0 
a The CAMP accumulation induced by the effector without 
addition of NGLH was considered as 100% stimulation 
b Mean values and SEM obtained from 3 different expt 
choleragen was observed. NG-LH did not antagonize 
FSH. 
No inhibitory action on LH stimulation was dis- 
played by nitroguanidinated serum albumin. The 
dependence of the action of NC-LH on its quaternary 
structure is indicated by fact that neither NG(LHo) 
nor NG-(LI-I@ (nitroguanidinated subunits) exhibit 
inhibitory properties on LH action. 
4. Discussion 
Some guanidylated derivatives can act at the same 
time as weak agonists and as antagonists [ 31. Binding 
to the receptors and adenylate cyclase stimulation oc- 
cur, but the steroidogenic effect is very low [3]. In 
comparison to the guanidyl derivatives, the NG-deriva- 
tive offers, from a chemical point of view, some new 
features. The presence of the NOa group suppresses 
the basic character of the guanidyl group. Another dif- 
ference is the less hydrophilic character of the NG- 
group. We have seen that as a result of these new features, 
the agonistic character of the derivative is abolished 
but its antagonistic properties are maintained and their 
scope extended to the stimulation of adenylate cyclase 
by LH. 
Our results underlined, on the other hand, the high 
specificity of nitroguanidyl lutropin in its action on 
cyclic AMP accumulation. NG-LH is without effect on 
the adenylate cyclase stimulation induced by fluoride, 
azide and prostaglandin E2. The action of FSH on 
juvenile ovarian adenylate cyclase which is mediated 
by FSH specific receptors different from those of LH, 
is unaltered by the presence of NG-LH. 
It must also be pointed out that NG-LH is without 
effect on the adenylate cyclase stimulation induced by 
the cholera toxin. Recent investigation of hormone- 
dependent adenylate cyclases indicates indeed that the 
stimulating action of choleragen and that of hormones 
are quite distinct and produced by different mech- 
anisms [lo,1 11. 
A diminution of the cyclic AMP accumulation under 
the usual baseline is obtained when the ovarian homog- 
enates are incubated in the presence of NG-LH (fig. 3). 
Since the action of the derivative is very specific, it 
seems reasonable to think that endogenous LH (or LH- 
like molecules) is responsible, at least in part, for the 
increase in the content of cyclic AMP usually produced 
during incubation of ovarian homogenates without 
addition of effecters. 
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NG-LH can act also as an antagonist of the action 
of LH on Leydig cells [ 121, inhibiting as well as the 
binding of LH to the membrane receptors, the cyclic 
AMP accumulation and the testosterone production. 
Some similarities exist therefore between the competi- 
tive inhibitory actions of NG- and that of G-LH [3]. 
However, there also exists a fundamental difference 
which must be emphasised: the NG-LH-receptor 
complex is unable to activate the membrane adenylate 
cyclase from any ‘compartment’ whereas G-LH acti- 
vates various gonadal adenylate cyclases [3,8]. NG-LH 
can act, therefore as an inhibitor of the stimulation of 
adenylate cyclase by LH whereas G-LH cannot. 
NG-LH is the first derivative obtained by chemical 
modification of the protein moiety of LH which acts 
exclusively as an antagonist. As could be expected, 
this action is exhibited only by the LH derivative but 
not by the derivatives obtained from the pre-separated 
subunits. By modification of the sugar moiety, some 
LH derivatives have been prepared which are also able 
to act as inhibitors of some activities of LH [ 13-161. 
All these inhibitors will afford new possibilities for 
studying the mechanism of action of LH and for in- 
vestigating its intervention in the physiology of 
reproduction. 
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